Skip to main content
SpringerLink
Log in

ICU-Acquired Infection: Mortality, Morbidity, and Costs

  • Chapter
Infection Control in the Intensive Care Unit

Part of the book series: Topics in Anaesthesia and Critical Care ((TIACC))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Nosocomial Infections Surveillance System (NNIS) System Report, data summary from January 1992 to June 1992, issued August 2002. Am J Infect Control 30:458–475

    Google Scholar 

  2. Richards MJ, Edwards JR, Culver DH et al (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27:887–892

    Article  PubMed  CAS  Google Scholar 

  3. Marshall JC, Sweeney D (1990) Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. Arch Surg 125:17–23

    PubMed  CAS  Google Scholar 

  4. Ponce de Leon-Rosales SP, Molinar-Ramos F, Dominguez-Cherit G, Rangel-Frausto MS, Vazquez-Ramos VG (2000) Prevalence of infections in intensive care units in Mexico: a multicenter study. Crit Care Med 28:1316–1321

    Article  PubMed  CAS  Google Scholar 

  5. Fagon JY, Novara A, Stephan F, Girou E, Safar M (1994) Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol 15:428–434

    Article  PubMed  CAS  Google Scholar 

  6. Nathens AB, Chu PTY, Marshall JC (1992) Nosocomial infection in the surgical intensive care unit. Infect Dis Clin North Am 6:657

    PubMed  CAS  Google Scholar 

  7. Schwieterman W, Roberts R (1997) FDA perspective on study design for therapies for severe sepsis. Sepsis 1:69

    Article  Google Scholar 

  8. Patrick DL, Pearlman RA, Starks HE, Cain KC, Cole WG, Uhlmann RF (1997) Validation of preferences for life-sustaining treatment: implications for advance care planning. Ann Intern Med 127:509–517

    PubMed  CAS  Google Scholar 

  9. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C (1999) The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 159:1249–1256

    PubMed  CAS  Google Scholar 

  10. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D et al (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276:889–918

    Article  PubMed  Google Scholar 

  11. Asensio A, Torres J (1999) Quantifying excess length of postoperative stay attributable to infections: a comparison of methods. J Clin Epidemiol 52:1249–1256

    Article  PubMed  CAS  Google Scholar 

  12. Second American Thoracic Society Workshop on Outcomes Research (2002) Understanding costs and cost-effectiveness in critical care. Am J Respir Crit Care Med 165:540–550

    Google Scholar 

  13. Liberati A, D’Amico R, Pifferi S et al (2004) Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care [Cochrane Review]. In: The Cochrane Library, Issue 1, Chichester, UK, John Wiley & Sons Ltd

    Google Scholar 

  14. Nathens AB, Marshall JC (1999) Selective decontamination of the digestive tract in surgical patients. Arch Surg 134:170–176

    Article  PubMed  CAS  Google Scholar 

  15. Warren DK, Zack JE, Elward AM, Cox MJ, Fraser VJ (2001) Nosocomial primary bloodstream infections in intensive care unit patients in a non-teaching community medical center: a 21-month prospective study. Clin Infect Dis 33:1329–1335

    Article  PubMed  CAS  Google Scholar 

  16. Gray J, Gossain S, Morris K (2001) Three-year survey of bacteremia and fungemia in a pediatric intensive care unit. Pediatr Infect Dis J 20:416–421

    Article  PubMed  CAS  Google Scholar 

  17. Jamal WY, El-Din K, Rotimi VO, Chugh TD (1999) An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait. J Hosp Infect 43:49–56

    Article  PubMed  CAS  Google Scholar 

  18. Crowe M, Ispahani P, Humphreys H, Kelley T, Winter R (1998) Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996. Eur J Clin Microbiol Infect Dis 17:377–384

    PubMed  CAS  Google Scholar 

  19. Pittet D, Thievent B, Wenzel RP, Li N, Auckenthaler R, Suter PM (1996) Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 153:684–693

    PubMed  CAS  Google Scholar 

  20. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A et al (1995) Incidence, risk factors, and outcomes of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 274:968–974

    Article  PubMed  CAS  Google Scholar 

  21. Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group (2001) Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163:1584–1590

    PubMed  CAS  Google Scholar 

  22. Raymond DP, Pelletier SJ, Crabtree TD, Gleason TG, Pruett TL, Sawyer RG (2001) Impact of bloodstream infection on outcomes among infected surgical inpatients. Ann Surg 233:549–555

    Article  PubMed  CAS  Google Scholar 

  23. Digiovine B, Chenoweth C, Watts C, Higgins M (1999) The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160:976–981

    PubMed  CAS  Google Scholar 

  24. Harbarth S, Rohner P, Auckenthaler R, Safran E, Sudre P, Pittet D (1999) Impact and pattern of gram-negative bacteraemia during 6 y at a large university hospital. Scand J Infect Dis 31:163–168

    Article  PubMed  CAS  Google Scholar 

  25. Blot S, Vandewoude K, Hoste E, Colardyn F (2003) Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa. J Hosp Infect 53:18–24

    Article  PubMed  CAS  Google Scholar 

  26. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (2002) Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113:480–485

    Article  PubMed  Google Scholar 

  27. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (2002) Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 162:2229–2235

    Article  PubMed  Google Scholar 

  28. Fagon J-Y, Chastre J, Vuagnat A, Trouillet J-L, Novara A, Gilbert C (1996) Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 275:866–869

    Article  PubMed  CAS  Google Scholar 

  29. Bercault N, Boulain T (2001) Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 29:2303–2309

    Article  PubMed  CAS  Google Scholar 

  30. Rello J, Quintana E, Ausina V, Castella J, Luquin M, Net A et al (1991) Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 100:439–444

    PubMed  CAS  Google Scholar 

  31. Bregeon F, Ciais V, Carret V, Gregoire R, Saux P, Gainnier M et al (2001) Is ventilator-associated pneumonia an independent risk factor for death? Anesthesiology 94:554–560

    Article  PubMed  CAS  Google Scholar 

  32. Markowicz P, Wolff M, Djedaini K, Cohen Y, Chastre J, Delclaux C et al (2000) Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Am J Respir Crit Care Med 161:1942–1948

    PubMed  CAS  Google Scholar 

  33. Cook D (2000) Ventilator associated pneumonia: perspectives on the burden of illness. Intensive Care Med 26[Suppl 1]:S31–S37

    Article  PubMed  Google Scholar 

  34. Rosenthal VD, Guzman S, Orellano PW (2003) Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 31:291–295

    Article  PubMed  Google Scholar 

  35. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505–511

    PubMed  CAS  Google Scholar 

  36. Fagon J-Y, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F et al (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 132:621–630

    PubMed  CAS  Google Scholar 

  37. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G et al (1999) A multicentre randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340:409–417

    Article  PubMed  CAS  Google Scholar 

  38. Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C (2002) An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 347:993–1000

    Article  PubMed  Google Scholar 

  39. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G et al (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785–792

    Article  PubMed  CAS  Google Scholar 

  40. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310

    Article  PubMed  CAS  Google Scholar 

  41. Brun-Buisson C, Roudot-Thoaval F, Girou E, Grenier-Sennelier C, Durand-Zaleski I (2003) The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med 29:1464–1471

    Article  PubMed  Google Scholar 

  42. Edbrooke DL, Hibbert CL, Kingsley JM, Smith S, Bright NM, Quinn JM (1999) The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit. Crit Care Med 27:1760–1767

    Article  PubMed  CAS  Google Scholar 

  43. Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598–1601

    Article  PubMed  CAS  Google Scholar 

  44. Shorr AF, Humphreys CW, Helman DL (2003) New choices for central venous catheters: potential financial implications. Chest 124:275–284

    Article  PubMed  Google Scholar 

  45. Marciante KD, Veenstra DL, Lipsky BA, Sainst S (2003) Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control 31:1–8

    Article  PubMed  Google Scholar 

  46. McConnell SA, Gubbins PO, Anaissie EJ (2003) Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection. Clin Infect Dis 37:65–72

    Article  PubMed  Google Scholar 

  47. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ et al (2003) Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 31:1312–1317

    Article  PubMed  Google Scholar 

  48. Kollef MH (1999) The prevention of ventilator-associated pneumonia. N Engl J Med 340:627–634

    Article  PubMed  CAS  Google Scholar 

  49. Zack JE, Garrison T, Trovillion E, Clinkscale D, Coopersmith CM, Fraser VJ et al (2002) Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 30:2407–2412

    Article  PubMed  Google Scholar 

  50. Sinuff T, Cook DJ (2003) Health technology assessment in the ICU: noninvasive positive pressure ventilation for acute respiratory failure. J Crit Care 18:59–67

    Article  PubMed  Google Scholar 

  51. Kotilainen HR, Keroack MA (1997) Cost analysis and clinical impact of weekly ventilator circuit changes in patients in intensive care unit. Am J Infect Control 25:117–120

    Article  PubMed  CAS  Google Scholar 

  52. Niederman MS (2001) Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 29[Suppl]:N114–N120

    Article  PubMed  CAS  Google Scholar 

  53. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C (1999) Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 282:1745–1751

    Article  PubMed  CAS  Google Scholar 

  54. Cosgrove SE, Kaye KS, Eliopoulos GM, Carmeli Y (2002) Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 162:185–190

    Article  PubMed  Google Scholar 

  55. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M (2002) Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162:2223–2228

    Article  PubMed  Google Scholar 

  56. Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG et al (2002) Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med 28:692–697

    Article  PubMed  Google Scholar 

  57. Bantar C, Sartori B, Vesco E, Heft C, Saul M, Salamone F et al (2003) A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibitoic consumption, cost savings, and bacterial resistance. Clin Infect Dis 37:180–186

    Article  PubMed  Google Scholar 

  58. Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW et al (2003) Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 31:1–11

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, and Interdepartmental Division of Critical Care, General Hospital and University of Toronto, Toronto, Canada

    J.C. Marshall & K.A.M. Marshall

Authors
  1. J.C. Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K.A.M. Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Microbiology, University of Liverpool Alder Hey Children’s Hospital, NHS Trust, Liverpool, UK

    H. K. F. van Saene M.D.

  2. Department of Critical Care Medicine, University Hospital of Getafe, Madrid, Spain

    M. A. De La Cal M.D.

  3. Emergency Department and Unit of Anesthesia and Intensive Care, Presidio Ospedaliero of Gorizia, Gorizia, Italy

    L. Silvestri M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Italia

About this chapter

Cite this chapter

Marshall, J., Marshall, K. (2005). ICU-Acquired Infection: Mortality, Morbidity, and Costs. In: van Saene, H.K.F., De La Cal, M.A., Silvestri, L. (eds) Infection Control in the Intensive Care Unit. Topics in Anaesthesia and Critical Care. Springer, Milano . https://doi.org/10.1007/88-470-0361-X_29

Download citation

  • DOI: https://doi.org/10.1007/88-470-0361-X_29

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0185-5

  • Online ISBN: 978-88-470-0361-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation